Ruchin Kansal's guest appearances

Ruchin Kansal

Seton Hall Undergraduate Leaders Podcast

Health Innovators

Steve Adubato's Lessons In Leadership with co-host Mary Gamba

GetAGoodStart.com Podcast

Bryan Price

Michael Reuter

Kevin Cummings

Katia Passerini

Warwick Fairfax

Cory Booker

Steve Anderson

Richard Lin

Joey Cofone

Julie Foudy

Erik Cabral

David Johnson

Ryan Hawk

David Moore

Paul Muldoon

OwlTail

Rick Thigpen

Steve Adubato and Mary Gamba talk with Ruchin Kansal, Business Leadership Center, Stillman School of Business, Seton Hall University and Kansal &amp; Company, about his passion innovation and for developing future leaders. Then, Steve and Mary are joined by Rick Thigpen, Senior VP, Corporate Citizenship for PSEG, who talks about historical leaders such as Thomas … Continue reading Lessons in Leadership: Ruchin Kansal and Rick Thigpen

Steve Adubato and Mary Gamba talk with Ruchin Kansal, Business Leadership Center, Stillman School of Business, Seton Hall University and Kansal &amp; Company, about his passion innovation and for developing future leaders. Then, Steve and Mary are joined by Rick Thigpen, Senior VP, Corporate Citizenship for PSEG, who talks about historical leaders such as Thomas … <a href="https://podcast.stand-deliver.com/2021/10/10/lessons-in-leadership-ruchin-kansal-and-rick-thigpen/" rel="nofollow" target="_blank">Continue reading Lessons in Leadership: Ruchin Kansal and Rick Thigpen</a>

Lessons in Leadership: Ruchin Kansal and Rick Thigpen

This week Scott talks with Professor Ruchin Kansal.

This week Scott talks with Professor Ruchin Kansal.

Ruchin Kansal - Binocular Explorer

This episode features Ruchin Kansal. He currently leads the School of Business' Center for Leadership Development. His professional journey has included stints as an Air Force cadet, an architect, a strategy &amp; transformation consultant with Ernst &amp; Young/Capgemini and Deloitte, founding leader of the first Business Innovation &amp; Transformation unit at Boehringer Ingelheim, and Senior Vice President and global head of digital strategy at Siemens Healthineers. He had the privilege to serve as a board member for Stanford Medicine X and was recognized with the Top 40 Healthcare Transformers Award by Medical, Marketing &amp; Media in 2016, and Boehringer Ingelheim President's Award for developing the company's first Patient Engagement Strategy.   Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry

This episode features Ruchin Kansal. He currently leads the School of Business' Center for Leadership Development. His professional journey has included stints as an Air Force cadet, an architect, a strategy &amp; transformation consultant with Ernst &amp; Young/Capgemini and Deloitte, founding leader of the first Business Innovation &amp; Transformation unit at Boehringer Ingelheim, and Senior Vice President and global head of digital strategy at Siemens Healthineers. He had the privilege to serve as a board member for Stanford Medicine X and was recognized with the Top 40 Healthcare Transformers Award by Medical, Marketing &amp; Media in 2016, and Boehringer Ingelheim President's Award for developing the company's first Patient Engagement Strategy. <a href="https://nam05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.amazon.com%2FRedefining-Innovation-Embracing-Biopharmaceutical-Industry%2Fdp%2F1138581046&amp;data=02%7C01%7Cwilliam.steck%40student.shu.edu%7C590a148ecab347f6704f08d872dc4c35%7C51f07c2253b744dfb97ca13261d71075%7C1%7C0%7C637385637777733220&amp;sdata=2sXMwRu%2F6AFNJqpIR5YXqPh93jGCFTGtvwa2nTWNU%2FY%3D&amp;reserved=0" rel="nofollow" target="_blank">Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry</a>

Episode 045 - Ruchin Kansal

The COVID-19 pandemic has affected how healthcare business is done.  But there are constants that never change: a patient (person) who needs care and the whole healthcare system that is (hopefully) designed to take care of the patient in the best fashion. Pre-pandemic healthcare saw quite a bit of disruption from outsiders who saw opportunities to disrupt the system, as-is, and technologies looking to bring in new efficiencies. Opportunities might arise, and pivots might be necessary - and lucrative - if you keep an open mind and remain pragmatic. In today’s episode, Ruchin Kansal shares his thoughts on the changing dynamics of how healthcare does business in a post-COVID landscape. Ruchin brings his experience with pivots - both personal and professional - to life for our listeners. He pairs his knowledge with humor and an abundance of tips and insights on the changing face of healthcare and the opportunities these changes bring to the table.   Here are the show highlights:  This is how the pandemic is affecting innovation and healthcare (2:50) The COVID crisis has disrupted the status-quo way of thinking about how healthcare is done in the United States (4:55) Breaking long-standing barriers in telemedicine (5:05) The CEOs of today are the kings of the past: Why leadership might be the key to making changes stick (5:38) This is the new normal in healthcare (6:52) Do you have to pivot your whole business? Heck no! (8:48) Don’t be afraid to leave what was - but do your due diligence (12:50) Not every pivot is a bad pivot (and you don’t need to pivot everything!) (15:55) The “Unicorn Business” and adjusting commercial models (16:49)    Guest Bio Ruchin Kansal is the Founder of Kansal &amp; Company, a consulting firm that coaches transformative leaders and companies in the art of how to find new markets and co-create with investors and entrepreneurs so they can build a better future of healthcare.  Finding “new markets” is old school for Ruchin who is an airforce pilot turned architect turned MBA - he is no stranger to the term “pivot.” Ruchin earned his MBA in Finance and Information Systems from the NYU Stern School of Business and is using his experience and expertise to help others in the business world reach their full potential. In addition to his decades-long career in the industry and his work with Kansal &amp; Company, Ruchin is also co-author of the book  Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry, which examines the evolution of the biopharmaceutical industry and defines a potential pathway for transforming the industry’s business model via the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." If you want to reach out to Ruchin to learn more about how Kansal &amp; Company might help you, or to simply ask questions, you can reach him at ruchin@kansal3c.com, on the Kansal &amp; Company website at  kansal3c.com or on linked in at Ruchin Kansal.

The COVID-19 pandemic has affected how healthcare business is done.  But there are constants that never change: a patient (person) who needs care and the whole healthcare system that is (hopefully) designed to take care of the patient in the best fashion. Pre-pandemic healthcare saw quite a bit of disruption from outsiders who saw opportunities to disrupt the system, as-is, and technologies looking to bring in new efficiencies. Opportunities might arise, and pivots might be necessary - and lucrative - if you keep an open mind and remain pragmatic. In today’s episode, Ruchin Kansal shares his thoughts on the changing dynamics of how healthcare does business in a post-COVID landscape. Ruchin brings his experience with pivots - both personal and professional - to life for our listeners. He pairs his knowledge with humor and an abundance of tips and insights on the changing face of healthcare and the opportunities these changes bring to the table. Here are the show highlights: <ul> <li>This is how the pandemic is affecting innovation and healthcare (2:50)</li> <li>The COVID crisis has disrupted the status-quo way of thinking about how healthcare is done in the United States (4:55)</li> <li>Breaking long-standing barriers in telemedicine (5:05)</li> <li>The CEOs of today are the kings of the past: Why leadership might be the key to making changes stick (5:38)</li> <li>This is the new normal in healthcare (6:52)</li> <li>Do you have to pivot your whole business? Heck no! (8:48)</li> <li>Don’t be afraid to leave what was - but do your due diligence (12:50)</li> <li>Not every pivot is a bad pivot (and you don’t need to pivot everything!) (15:55)</li> <li>The “Unicorn Business” and adjusting commercial models (16:49)</li> </ul> Guest Bio Ruchin Kansal is the Founder of Kansal &amp; Company, a consulting firm that coaches transformative leaders and companies in the art of how to find new markets and co-create with investors and entrepreneurs so they can build a better future of healthcare.  Finding “new markets” is old school for Ruchin who is an airforce pilot turned architect turned MBA - he is no stranger to the term “pivot.” Ruchin earned his MBA in Finance and Information Systems from the NYU Stern School of Business and is using his experience and expertise to help others in the business world reach their full potential. In addition to his decades-long career in the industry and his work with Kansal &amp; Company, Ruchin is also co-author of the book <a href="https://www.amazon.com/Redefining-Innovation-Embracing-Biopharmaceutical-Industry/dp/1138581046" rel="nofollow" target="_blank"> Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry</a>, which examines the evolution of the biopharmaceutical industry and defines a potential pathway for transforming the industry’s business model via the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." If you want to reach out to Ruchin to learn more about how Kansal &amp; Company might help you, or to simply ask questions, you can reach him at <a href="mailto:ruchin@kansal3c.com">ruchin@kansal3c.com</a>, on the Kansal &amp; Company website at  <a href="http://kansal3c.com" rel="nofollow" target="_blank">kansal3c.com</a> or on linked in at <a href="https://www.linkedin.com/in/ruchinkansal/" rel="nofollow" target="_blank">Ruchin Kansal</a>.